Clinical, anatomopathological manifestations and laboratory findings of Covid-19 in adults: a narative review
DOI:
https://doi.org/10.34119/bjhrv6n1-346Keywords:
Covid-19, signs and symptoms, diagnosis, adult populationAbstract
Introduction: SARS-CoV-2, the causative agent of the COVID-19 pandemics can cause anything from asymptomatic infections to several clinical manifestations. This study aims to present signs, symptoms, anatomopathological diagnosis, clinical diagnosis and laboratory findings in patients with COVID-19 in a narrative review. Methods: Narrative review of studies available in PubMed/Medline database about clinical manifestations in adult patients which were published in English, Portuguese and Spanish. Results: 547 articles were found, out of which 450 were excluded and 3 studies were added to the existing ones, totalizing 100 articles that composed the analyzed data. The main signs and symptoms were fever, dry cough, fatigue, dyspnea, pneumonia, headache, myalgia, vomiting, diarrhea, productive cough, acute myocardial injury, coagulopathy and olfactory and taste disorders. Conclusions: The findings suggest a great variety and complexity of Covid-19 clinical presentations indicating that, many differential diagnoses must be considered.
References
SÃO PAULO. Conselho Regional de Farmácia do estado de São Paulo. Manual de Orientação ao farmacêutico: COVID-19. São Paulo: Conselho Regional de Farmácia, [2020]. Disponível em: http://www.crfsp.org.br/images/arquivos/Manual_orientacao.pdf. Acesso em: 10 ago. 2020.
Wu D, Wu T, Liu Q, Yang Z. The SARS-COV-2 outbreak: What we know. Int J Infect Dis. 2020; 94:44-48. doi:10.1016/j.ijid.2020.03.004
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb;395(10223):507-13.
Liu L, Hong X, Su X, Chen H, Zhang D, Tang S, et al. Optimizing screening strategies for coronavirus disease 2019: a study from Middle China. J Infect Public Health. 2020 Jun;13(6):868-72.
Cespedes MS, Souza JC. Sars-CoV-2: a clinical update - II. AMB Rev Assoc Med Bras. 2020 Apr;66(4):547-57.
Kang S, Peng W, Zhu Y, Lu S, Zhou M, Lin W, et al. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment. Int J Antimicrob Agents. 2020May;55(5):105950.
Zheng Q, Lu Y, Lure F, Jaeger S, Lu P. Clinical and radiological features of novel coronavirus pneumonia. J Xray Sci Technol. 2020;28(3):391-404.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–93.
Wang L, Shen Y, Li M, Chuang H, Ye Y, Zhao H, Wang H. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol. 2020 Oct;267(10):2777-89.
Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol. 2020 Oct;92(10):1902-14.
Mesquita RR, Junior LCFS, Santana FMS, Oliveira TF, Alcântara RC, Arnozo GM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021 Apr;133(7-8):377-82.
Neto ARS, Carvalho ARB, Oliveira EMN, Magalhães RLB, Moura MEB, Freitas DRJ. Symptomatic manifestations of the disease caused by coronavirus (COVID-19) in adults: systematic review. Rev Gaucha Enferm. 2021 May 19;42(spe):e20200205.
Islam MA, Alam SS, Kundu S, Hossan T, Kamal MA, Cavestro C. Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients. Front Neurol. 2020;11:562634. Published 2020 Nov 27.
Giri M, Puri A, Wang T, Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci Prog. 2021;104(1):368504211000906.
Zhou Y, Li W, Wang D, Mao L, Jin H, Li Y, et al. Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management. Stroke Vasc Neurol. 2020 May;5(2):177-9.
Abobaker A, Raba A, Alzwi A. Extrapulmonary and atypical clinical presentations of COVID-19. J Med Virol. 2020 Nov;92(11):2458-64.
Genga Y, Wei Z, Qian H, Huang J, Lodato R, Castriotta R. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107228.
Mahenthiran AK, Mahenthiran AK, Mahenthiran J. Cardiovascular system and COVID-19: manifestations and therapeutics. Rev Cardiovasc Med. 2020;21(3):399-409.
Harb J, Noureldine H, Chedid G, Eldine M, Abdallah D, Chedid N, et al. SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review. Pathog Dis. 2020 Jun;78(4):ftaa033.
Baj J, Karakuła-Juchnowicz H, Teresinsk G, Buszewicz G, Ciesielka M, Sitarz E, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020 Jun;9(6):1753.
Boukhris M, Hillani A, Moroni F, Annabi M, Addad F, Ribeiro M, et al. Cardiovascular Implications of the COVID-19 Pandemic: a global perspective. Can J Cardiol. 2020;36(7):1068-80.
Oleynick C. Symptoms of pleurisy as the initial presentation of COVID-19. Am J Case Rep. 2020 Jul;21:e925775
Kopel J, Perisetti A, Gajendran M, Boregowda U, Goyal H. Clinical Insights into the Gastrointestinal Manifestations of COVID 19. Dig Dis Sci. 2020 Jul;65(7):1932-9.
Su S, Shen J, Zhu L, Qiu Y, He J, Tan J, et al. Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges. Ther Adv Gastroenterol. 2020 Jun;13:1-12.
Zhang H, Li H, Lyu J, Lei X, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020 Jul;96:19-24.
Zarifian A, Bidary M Z, Arekhi S, Rafiee M, Gholamalizadeh H, Amiriani A, et al. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: a systematic review and meta-analysis. J Med Virol. 2020 Jul;93(1):336-50.
Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology 2020 Jul;159(1):320-34.e27.
Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc. 2020 Jun;83(6):521-3.
Gupta A, Madhavan M, Sehgal K, Nair N, Mahajan S, Sehrawat T, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020 Jul;26(7):1017-32.
Behzad S, Aghaghazvini L, Radmard A, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: radiologic and clinical overview. Clin Imaging. 2020 Oct;66:35-41.
Abdalhadi A, Alkhatib M, Mismar AY, Awouda W, Albarqouni L. Can COVID 19 present like appendicitis? IDCases. 2020;21:e00860.
Ahmed AOE, Badawi M, Ahmed K, Mohamed MFH. Case report: COVID-19 masquerading as an acute surgical abdomen. Am J Trop Med Hyg. 2020 Aug;103(2):841-3.
Lai C, Ko W, Lee P, Jean S, Hsueh P. Extra-respiratory manifestations of COVID-19. Int J Antimicrob. 2020;56(2):106024.
Mao R, Qiu Y, He J, Tan J, Li X, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78.
Su TH, Kao JH. The clinical manifestations and management of COVID-19-related liver injury. J Formos Med Assoc. 2020;119(6):1016-8.
Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;98(2):75-81.
Wollina U, Karadag A, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous in COVID-19 patients: a review. Dermatol Ther. 2020;33(5):e13549.
Young S, Fernandez A. Skin manifestations of COVID-19. Cleve Clin J Med May. 2020 May 14. Epub ahead of print.
Jiménez P, Nieto D, Villaverde R, Cruz C, Romani J, Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Apr;183(1):71-7.
Dalal A, Jakhar D, Agarwal V, Beniwal R. Dermatological findings in SARS-CoV-2 positive patients: anobservational study from North India. Dermatol Ther. 2020 Nov;33(6):e13849.
Criado P, Abdalla B, Assis I, Mello C, Caputo G, Vieira I. Are the cutaneous manifestations during or due to SARS CoV 2 infection/COVID 19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020 Aug;69(8):745-56.
Casas CJ, Català A, Hernández GC, Rodríguez-Jiménez P, Fernández-Nieto D, Lario ARV, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spainwith 375 cases. Br J Dermatol. 2020 Jul;183(1):71-7.
Potekaev NN, Zhukova OV, Protsenko DN, Demina OM, Khlystova EA, Bogin V. Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification. Int J Dermatol. 2020 Aug;59(8):1000-9.
Putra BE, Adiarto S, Dewayanti SR, Juzar DA. Viral exanthem with “pin and needles sensation” on extremities of COVID‐19 patient. Int J Infect Dis. 2020 Jul;96:355-8.
Schwartzberg LN, Advani S, Clancy DC, Lin A, Jorizzo JL. A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis. Skin Health Dis. 2021;1(2):e20.
Unique skin manifestations of COVID-19: is drug eruption specific to COVID-19? [letter]. J Dermatol Sci. 2020 Jul;99(1):62-4.
Suter P, Mooser B, Thien HPPH. Erythema nodosum as a cutaneous manifestation of COVID-19 infection. BMJ Case Rep. 2020;13:e236613. doi:10.1136/bcr-2020-236613
Nawabi J, Morotti A, Wildgruber M, Boulouis G, Kraehling H, Schlunk F, et al. Clinical and imaging characteristics in patients with SARS-CoV-2 infection and acute intracranial hemorrhage. J Clin Med. 2020;9(8):2543.
Karadaş O, Öztürk B, Sonkaya A. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020;41:1991-5.
Mahalakshmi AM, Ray B, Tuladhar S, Bhat A, Paneyala S, Patteswari D, et al. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis. 2021 Mar;9(1):48-58.
Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020 May;26(5):499-501.
Ahmad I, Rathore F. Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020 Jul;77:8-12.
Beghi E, Feigin V, Caso V, Santalucia P, Logroscino G. COVID-19 infection and neurological complications: present findings and future predictions. Neuroepidemiology. 2020Jul;54(5):364-9.
Mishra AK, Sahu KK, George AA, Sargent J, Lal A. Cerebrovascular events in COVID-19 patients. Monaldi Arch Chest Dis. 2020;90(1341):333-6.
Moro E, Beghi E, Helbok R, Bassetti C, Cavallieri F, Berecki D, et al. The international EAN survey on neurological symptoms in patients with COVID-19 infection. Eur J Neurol. 2020 Jun;27(9):1727-37.
Werner C, Scullen T, Mathkour M, Zeoli T, Beighley A, Kilgore MD, et al. Neurological impact of Coronavirus Disease of 2019: practical considerations for the Neuroscience Community. World Neurosurg. 2020 Jul;139:344-54.
Gupta I, Reddy MK, Hussain MM, Murthy PM, Robert CA. Atypical neurological manifestations of COVID-19. Cureus. 2020 Jun;12(6):e8518.
Afshar H, Yassin Z, Kalantari S, Aloosh O, Lotf T, Moghaddasi M. Evolution and resolution of brain involvement associated with SARS- CoV2 infection: a close clinical – paraclinical follow up study of a case. Mult Scler Relat Disord. 2020;43:102216
Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: is there an association? Neurocritic Care. 2020 May;34(1):139-43.
Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterlé H, et al. Neurologic and neuroimaging findings in patients with COVID-19. Neurol. 2020 Sept;95(13):1868-82.
Baig A. Updates on what ACS Reported: emerging evidences of COVID-19 with nervous system involvement. ACS Chem Neurosci. 2020;11(9):1204-5.
Brouwer M, Ascione T, Pagliano P. Neurologic aspects of COVID-19: a concise review. Infez Med. 2020;28(1):42-5.
Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Victor EA. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol. [online periodic]. 2020 Jun [access 11 feb 2021]. Available in: https://www.frontiersin.org/articles/10.3389/fneur.2020.00687/full
Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Hulya Caskurlu H. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 020 Aug;97:208-11.
Tsai ST, Lu MK, San S, Tsai CH. The neurologic manifestations of coronavirus disease 2019 pandemic: a systemic review. Front Neurol. 2020 May 19;11:498.
Romoli M, Jelcic I, Bernard-Valnet R, Azorín DG, Mancinelli L, Akhvlediani T, et al. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol. 2020 Sep;27(9):1712-26.
Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: a typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104989.
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–40.
Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020 Jul;41(7):1657-8.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun;77(6):1-9.
Saniasiaya J, Islam MA, Abdullah B. Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients. Laryngoscope. 2021;131(4):865-78.
Costa KVT, Carnaúba ATL, Rocha KW, Andrade KCL, Ferreira SMS, Menezes PL. Olfactory and taste disorders in COVID-19: a systematic review. Braz J Otorhinolaryngol. 2020 Nov-Dec;86(6):781-92.
Biadsee A, Biadsee A, Kassem F, Dagan O, Masarwa S, Ormianer Z. Olfactory and oral manifestations of COVID-19: sex-related symptoms: a potential pathway to early diagnosis. Head Neck Surg. 2020;163(4):722-8.
Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Clin Sci. 2020Apr;104(6):748-51.
Costa ST, Fontes ML, Reis FF, Falcão M. SARS-COV-2 in ophthalmology: current evidence and standards for clinical practice. Acta Med Port. 2020 Sep;33(9):593-600
Guo D, Xia J, Shen Y, Tong J. SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva. Virol J. 2020 Oct;92(10):1757-8.
Latalska M, Mackiewicz J. The implication of ocular manifestation of COVID-19 for medical staff and patients – systematic review. Ann Agric Environ Med. 2020;27(2):165-70.
Ling XC, Kang EY, Lin JY, et al. Ocular manifestation, comorbidities, and detection of severe acute respiratory syndrome-coronavirus 2 from conjunctiva in coronavirus disease 2019: A systematic review and meta-analysis. Taiwan J Ophthalmol. 2020;10(3):153-66. Published 2020 Sep 16.
Milby KM, Atallah AN, Rocha-Filho CR, Pinto ACPN, Rocha APD, Reis FSA, et al. SARS-CoV-2 and arbovirus infection: a rapid systematic review. Sao Paulo Med J. 2020 Nov-Dec;138(6):498-504.
Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context. J Fr Ophtalmol. 2020May;43(5):389-91. PMID: 32334847; PMCID: PMC7164841.
Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID‐19 patients—a systematic review. J Card Surg. 2020;35:1988–2008.
Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, et al. Cardiovascular manifestations in severe and critical patients with COVID-19. J Clin Investig. 2020;43(7):796-802.
Hu L, Gong L, Jiang Z, Wang Q, Zou Y, Zhu L. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia. Crit Care. 2020 May 26;24(1):257.
Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, Di Giusto F, Crea F. 2019 novel coronavirus: what is currently known, cardiovascular implications and management. Minerva Cardioangiol. 2020 May 29. doi: 10.23736/S0026-4725.20.05311-6. Epub ahead of print.
Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149.
Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019. Chest J. 2020 Sep;158(3):1143-63. PMID: 32502594; PMCID: PMC7265858.
Shawkat A, Merrell ET, Fadel GA, Amzuta I, Amin H, Shah AJ, et al. Multiple thrombotic events in a 67-year-old man 2 weeks after testing positive for SARS-CoV-2: a case report. Am J Case Rep. 2020 Jul 22;21:e925786.
Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020 Jul 23;136(4):489-500.
Słomka A, Kowalewski M, Żekanowska E. Coronavirus disease 2019 (COVID–19): a short review on hematological manifestations. Pathogens 2020;9(6):493.
Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis. 2020;22(6):e13427.
Díaz Rodríguez M, Jimenez Romera A, Villarroel M. Oral manifestations associated with COVID-19. Oral Dis. 2020 Jul 22;10.1111/odi.13555.
Souza LC de, Silva TO da, Pinheiro AR da S, Santos F da S dos. SARS-CoV, MERS-CoV e SARS-CoV-2: uma revisão narrativa dos principais Coronavírus do século / SARS-CoV, MERS-CoV e SARS-CoV-2: a narrative review of the main Coronaviruses of the century. Brazilian Journal of Health Review. 2021;4(1):1419–39.
Gomes GGC, Bisco NCB, Paulo MF, Fabrin SCV, Fioco EM, Verri ED, et al. Perfil epidemiológico da Nova Doença Infecciosa do Coronavírus - COVID-19 (Sars-Cov-2) no mundo: Estudo descritivo, janeiro-junho de 2020. Brazilian Journal of Health Review. 2020;3(4):7993–8007.
Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) 2021 Mar;20(1):219-21.
Li H, Wang B, Ning L, Luo Y, Xiang S. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia. Platelets 2020 Aug 17;31(6):825-6.
Supplementary archive:
Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41.
Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: A case report and review of literature. Eur J Ophthalmol. 2020 Jul 24;1120672120946287.
Cheung K, Hung I, Chan P, Lung K, Tso E, Liu R, et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterol. 2020 Jul;159(1):81-95
Eder P, Lodyga M, Dobrowolska A, Rydzewska G, Kamhieh Milz J. Addressing multiple gastroenterological aspects of coronavirus disease 2019. Pol Arch Intern Med. 2020 May;130(5):420-30.
Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute Symptomatic Seizures in Critically Ill Patients with COVID-19: is there an association? Neurocritic Care. 2020 May;34(1):139-43.
